adplus-dvertising
Connect with us

News

Countries weigh need for booster COVID-19 shots

Published

 on

COVID-19 vaccine booster shots will be made widely available to Americans starting on Sept. 20, U.S. health officials said, citing data showing diminishing protection from the initial vaccinations as infections with the Delta variant rise.

In recent weeks several countries – including Israel, Germany and France – have decided to offer booster shots to older adults and people with weak immune systems. European Union officials said they do not yet see a need to give booster shots to the general population.

As of yet, there is no consensus among scientists and agencies that a third dose is necessary.

The World Health Organization (WHO) said on Aug. 18 that current data does not indicate a need for COVID-19 booster shots, adding that the most vulnerable people worldwide should be fully vaccinated before high-income countries deploy a top-up.

The following outlines the options countries and regions are considering on the issue:

UNITED STATES

COVID-19 vaccine booster shots will be made widely available from Sept. 20 to Americans who received their initial inoculation of two-dose COVID-19 vaccines made by Moderna and by Pfizer and BioNTech AG at least eight months earlier, U.S. health officials said on August 18.

EUROPEAN UNION

The European Union’s drugs regulator said on Aug. 6 there’s still not enough data to recommend COVID-19 vaccine boosters.

Recent supply contracts with Pfizer/BioNTech and Moderna have included the potential for the bloc to buy booster shots.

AUSTRIA

Austria plans to start COVID-19 vaccine booster shots on Oct. 17, nine months after the first group of people to get the shots received their second dose.

BELGIUM

Belgium has authorised the use of boosters – specifically mRNA shots – for immunosuppressed people. More data is needed before considering extra shots for the elderly and people living in nursing homes.

BRITAIN

Britain has begun planning for a booster campaign starting later this year after top vaccine advisers said it might be necessary to give third shots to the elderly and most vulnerable from September. It said it would buy 60 million more doses of Pfizer/BioNTech’s vaccine ahead of the possible booster programme, bringing its total order of the shot to 100 million doses.

BRAZIL

Brazilians should prepare for annual COVID-19 immunisations to reinforce vaccines, the head of public-sector laboratory Butantan said in May.

CAMBODIA

Cambodia started on Aug. 12 offering AstraZeneca booster shots to those who have received the inactivated virus vaccines developed by Sinopharm and Sinovac.

CANADA

The Canadian province of Ontario will begin offering third COVID-19 vaccine doses to vulnerable people as early as this week, its chief medical officer said on Aug. 17.

CHILE

Chile began on Aug. 11 administering booster shots to those already inoculated with Sinovac’s COVID-19 vaccine in a bid to lock in early success following one of the world’s fastest mass vaccination drives.

CZECH REPUBLIC

Some groups will probably need to get a third vaccine shot, Health Minister Adam Vojtech said on Aug. 17.

DOMINICAN REPUBLIC

Dominican health authorities started distributing a voluntary third vaccine dose in early July.

ECUADOR

Ecuador will administer a third dose of the coronavirus vaccine to people with weak immune systems and will carry out tests to determine if the rest of the inoculated population also needs a booster, Health Minister Ximena Garzon said on Aug. 18.

FINLAND

It has not made a decision on the recommendation of a third dose but is expected to do so in August.

FRANCE

President Emmanuel Macron said France was working on rolling out third COVID-19 vaccine doses to the elderly and vulnerable from September.

GERMANY

Germany will in September start to offer a booster shot to vulnerable people, such as the elderly and those with weak immune systems. The shots will be mRNA-vaccines from Pfizer/BioNTech and Moderna regardless of what was used previously.

HUNGARY

Hungary has been offering an optional third dose of a COVID-19 vaccine from Aug. 1.

INDONESIA

Indonesia started giving booster shots produced by Moderna to medical workers in July and is considering extra doses for wider use.

ISRAEL

Israel in July started offering a third shot of the Pfizer/BioNTech vaccine to people aged over 60 and to those over 50 from Aug. 13. It continues to administer extra doses to health workers.

RUSSIA

Health clinics in Moscow started offering booster shots in July to people vaccinated six months ago or more, making Russia one of the first countries to begin re-vaccination.

PHILLIPINES

The Philippines is allotting 45.3 billion pesos ($899 million) for COVID-19 booster shots under its 2022 budget, an official said on Aug. 19, even as health authorities have yet to conclude there is a need for a third dose.

SINGAPORE

Singapore said in May it was making plans for booster shots later this year or early next year, if necessary.

SOUTH KOREA

South Korea said in June it plans to secure more mRNA vaccines to use as boosters next year for its entire population of 52 million.

SLOVENIA

Slovenia will most probably start recommending a third vaccine dose, the head of the National advisory committee on immunization, Bojana Beovic, told the Slovenian national broadcaster on Aug. 18.

SWEDEN

The majority of Swedes will be offered a booster shot against COVID in 2022, while high risk groups could get a third shot this autumn, the health authority said on Aug. 3.

SWITZERLAND

Switzerland has ordered 43 million doses of vaccines, including preparations for potential booster shots in 2022, should they be needed, the Health Ministry said.

GULF STATES

The United Arab Emirates will start providing a booster shot to all fully vaccinated people. The shot will be available to people considered at high risk three months after their second vaccine dose, and six months for others.

In June, the UAE and Bahrain made the Pfizer vaccine available as a booster shot to those initially immunised with a vaccine developed by China’s Sinopharm.

THAILAND

Thailand plans to give booster shots of imported mRNA vaccine to its front-line workers – who were given imported Sinovac before the locally manufactured AstraZeneca vaccine was available in June.

TURKEY

Turkey is allowing people who were inoculated with Sinovac’s coronavirus vaccine to take an additional Pfizer dose, the health ministry said on Aug. 16.

URUGUAY

Uruguay offers a Pfizer dose for those fully vaccinated wth Sinovac’s Coronavac. https://bit.ly/37SFw5P

COMPANIES

The U.S. Food and Drug Administration (FDA) authorized a third dose of COVID-19 vaccines by Pfizer-BioNTech and Moderna on Aug. 13 for people with compromised immune systems.

Pfizer and BioNtech have submitted data to the FDA for COVID-19 vaccine booster authorization and plan to submit it as well to the European Medicines Agency (EMA) and other regulatory authorities in the coming weeks.

Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest EU supply contracts, the Financial Times reported on Aug. 1.

Moderna had earlier struck deals with Spain’s Rovi and Switzerland’s Lonza at a Dutch plant that would boost 50-microgram dose production – half the level of its original shots – in Europe to up to 600 million doses annually, with the capacity due to come on line this year.

On Aug. 5, Moderna said that its COVID-19 shot was about 93% effective four to six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial.

It expects, however, a COVID-19 booster to be necessary prior to the winter season.

AstraZeneca said it was looking into how long the vaccine’s protection lasts and if a booster dose would be needed.

 

(Reporting by Matthias Blamont in Paris, Michael Erman in New York, Julie Steenhuysen in Chicago, John Miller in Zurich, Ludwig Burger in Frankfurt, Miyoung Kim in Singapore, Alistair Smout in London, Essi Lehto in Helsinki, Stephanie Nebehay in Geneva, Maayan Lubell in Jerusalem, Dagmarah Mackos, Pawel Goraj, Veronica Snoj in Gdansk; Editing by Josephine Mason, Barbara Lewis and Emelia Sithole-Matarise)

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending